Peer review reports
From: CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling
Original Submission | ||
---|---|---|
10 Mar 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
8 Apr 2022 | Reviewed | Reviewer Report |
10 Apr 2022 | Reviewed | Reviewer Report |
20 Dec 2022 | Author responded | Author comments - Xuan Zhu |
Resubmission - Version 4 | ||
20 Dec 2022 | Submitted | Manuscript version 4 |
8 Jan 2023 | Author responded | Author comments - Xuan Zhu |
Resubmission - Version 5 | ||
8 Jan 2023 | Submitted | Manuscript version 5 |
9 Jan 2023 | Author responded | Author comments - Xuan Zhu |
Resubmission - Version 6 | ||
9 Jan 2023 | Submitted | Manuscript version 6 |
13 Jan 2023 | Reviewed | Reviewer Report |
29 Jan 2023 | Author responded | Author comments - Xuan Zhu |
Resubmission - Version 7 | ||
29 Jan 2023 | Submitted | Manuscript version 7 |
1 Feb 2023 | Author responded | Author comments - Xuan Zhu |
Resubmission - Version 8 | ||
1 Feb 2023 | Submitted | Manuscript version 8 |
2 Feb 2023 | Author responded | Author comments - Xuan Zhu |
Resubmission - Version 9 | ||
2 Feb 2023 | Submitted | Manuscript version 9 |
Publishing | ||
6 Feb 2023 | Editorially accepted | |
13 Feb 2023 | Article published | 10.1186/s12885-023-10615-w |